School of Government, Pontifical Catholic University of Chile, Santiago, Chile; Millennium Nucleus for the Study of the Life Course and Vulnerability, Santiago, Chile.
Inter-American Development Bank, Washington, DC, USA.
Lancet Glob Health. 2019 Oct;7(10):e1448-e1457. doi: 10.1016/S2214-109X(19)30326-2. Epub 2019 Aug 9.
On Dec 1, 2006, Mexico's public health-care insurance scheme, Seguro Popular, implemented the Medical Insurance Century XXI (SMSXXI) programme, to provide insurance to children younger than 5 years without social security. SMSXXI aims to increase access to health services, decrease out-of-pocket health expenses (OOPHE), and reduce health inequities. SMSXXI covers uninsured, primarily low-income, populations who might be most at risk of the financial and health consequences of costly medical interventions.
We assessed the effects of SMSXXI on health outcomes and financial protection for Mexico's children using multiple nationally representative surveys and administrative data sources spanning 2001-16. The identification of effects relied on detailed hospital-level affiliation data mapping the geographical expansion of SMSXXI's coverage across the country over time. The units of analysis included hospitals, households, and children. Primary outcomes were neonatal and infant mortality, self-reported morbidity (health status, influenza, and diarrhoea), and child's height. Secondary outcomes were OOPHE, hospital discharges, and quality of service provision. Effects controlled for fixed and time-variant confounders using double-difference and triple-difference estimation strategies. Where feasible, we also estimated effects using exogenous variation in programme eligibility rules that limited enrolment in SMSXXI to children born after Dec 1, 2006.
SMSXXI was not associated with early (<1 week) neonatal mortality, but was associated with a reduction in late (<28 days) neonatal mortality by 0·139 deaths per 1000 livebirths (95% CI 0·032-0·246), or 7% (2-12) relative to the comparison base of 1·98 deaths per 1000 livebirths in 2006. SMSXI was associated with a reduction in infant mortality from conditions covered by the programme by 0·147 deaths per 1000 livebirths (0·023-0·271), or 5% (1-10) relative to the comparison base of 2·73 deaths per 1000 livebirths. The effects were largest in high baseline mortality areas. Long-term health effects, 8 years after the onset of SMSXXI, were reflected in a 0·434 cm (0·404-0·459) height increase for birth cohorts exposed to the programme and an average effect on height of 0·879 cm (0·821-0·932) for low-income populations. About 3-6 years after SMSXXI started, children reported having better health status and lower incidence of influenza and diarrhoea. The programme led to a 14% reduction (7-28) in OOPHE, primarily from hospital-related expenses. No effects were detected on hospital discharges, suggesting that SMSXXI might not have increased use.
SMSXXI promoted access to covered interventions and encouraged better primary care. The programme also promoted increased supply and quality of care by improving human and physical resources sensitive to unmet needs. Increased resource availability and improved supply of health care, rather than increased use, contributed to reduce infant mortality and improved long-term health as proxied by self-reported morbidity and child height. Consistent with the programme's focus on uninsured and low-income populations, the effects on mortality, long-term health status, and OOPHE were concentrated in vulnerable groups.
Inter-American Development Bank.
2006 年 12 月 1 日,墨西哥公共医疗保险计划“大众医疗保险”(Seguro Popular)实施了“医疗保险 21 世纪”(SMSXXI)计划,为没有社会保险的 5 岁以下儿童提供保险。SMSXXI 的目标是增加获得医疗服务的机会,减少自费医疗支出(OOPHE),并减少卫生不平等。SMSXXI 涵盖了没有保险的、主要是低收入人群,他们最有可能因昂贵的医疗干预而面临经济和健康后果的风险。
我们使用多个全国代表性调查和行政数据源,评估了 SMSXXI 对墨西哥儿童健康结果和财务保护的影响,这些数据涵盖了 2001 年至 2016 年期间。效果的识别依赖于详细的医院关联数据,这些数据反映了 SMSXXI 覆盖范围在全国范围内的地理扩展情况。分析单位包括医院、家庭和儿童。主要结果是新生儿和婴儿死亡率、自我报告的发病率(健康状况、流感和腹泻)和儿童身高。次要结果是自费医疗支出、医院出院率和服务质量提供。使用双重差异和三重差异估计策略,通过固定和时变混杂因素控制效果。在可行的情况下,我们还使用计划资格规则的外生变化来估计效果,这些规则将 SMSXXI 的入学资格限制在 2006 年 12 月 1 日以后出生的儿童。
SMSXXI 与早期(<1 周)新生儿死亡率无关,但与晚期(<28 天)新生儿死亡率降低有关,每 1000 例活产中降低 0.139 例(95%CI 0.032-0.246),或与 2006 年每 1000 例活产中 1.98 例的比较基数相比降低 7%(2-12)。SMSXI 与覆盖范围内的婴儿死亡率降低有关,每 1000 例活产中降低 0.147 例(0.023-0.271),或与 2.73 例每 1000 例活产的比较基数相比降低 5%(1-10)。在基线死亡率较高的地区,效果最大。SMSXXI 开始 8 年后的长期健康影响反映在暴露于该计划的出生队列的身高增加了 0.434 厘米(0.404-0.459),对于低收入人群,平均身高影响为 0.879 厘米(0.821-0.932)。在 SMSXXI 开始大约 3-6 年后,儿童报告健康状况有所改善,流感和腹泻的发病率也有所降低。该计划使自费医疗支出减少了 14%(7-28),主要来自与医院相关的费用。没有发现对医院出院率的影响,这表明 SMSXXI 可能没有增加使用。
SMSXXI 促进了覆盖干预措施的获得,并鼓励了更好的初级保健。该计划还通过提高对未满足需求敏感的人力和物力资源,促进了更多的供应和更高的医疗服务质量。增加的资源可用性和改善的医疗保健供应,而不是增加使用,有助于降低婴儿死亡率,并改善自我报告的发病率和儿童身高所代表的长期健康状况。与该计划关注无保险和低收入人群相一致,死亡率、长期健康状况和自费医疗支出的影响集中在弱势群体。
美洲开发银行。